Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1990;101:227–233.

Current concepts of control measures for influenza.

R Dolin 1
PMCID: PMC2376495  PMID: 2486444

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clements M. L., Betts R. F., Murphy B. R. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet. 1984 Mar 31;1(8379):705–708. doi: 10.1016/s0140-6736(84)92222-0. [DOI] [PubMed] [Google Scholar]
  2. Clover R. D., Crawford S. A., Abell T. D., Ramsey C. N., Jr, Glezen W. P., Couch R. B. Effectiveness of rimantadine prophylaxis of children within families. Am J Dis Child. 1986 Jul;140(7):706–709. doi: 10.1001/archpedi.1986.02140210104036. [DOI] [PubMed] [Google Scholar]
  3. Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science. 1985 Mar 15;227(4692):1296–1303. doi: 10.1126/science.2983421. [DOI] [PubMed] [Google Scholar]
  4. Dolin R., Reichman R. C., Madore H. P., Maynard R., Linton P. N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2;307(10):580–584. doi: 10.1056/NEJM198209023071002. [DOI] [PubMed] [Google Scholar]
  5. Glezen W. P., Couch R. B. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978 Mar 16;298(11):587–592. doi: 10.1056/NEJM197803162981103. [DOI] [PubMed] [Google Scholar]
  6. Glezen W. P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25–44. doi: 10.1093/oxfordjournals.epirev.a036250. [DOI] [PubMed] [Google Scholar]
  7. La Montagne J. R., Noble G. R., Quinnan G. V., Curlin G. T., Blackwelder W. C., Smith J. I., Ennis F. A., Bozeman F. M. Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis. 1983 Jul-Aug;5(4):723–736. doi: 10.1093/clinids/5.4.723. [DOI] [PubMed] [Google Scholar]
  8. Maassab H. F. Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol. 1969 Mar;102(3):728–732. [PubMed] [Google Scholar]
  9. Meiklejohn G., Eickhoff T. C., Graves P., I J. Antigenic drift and efficacy of influenza virus vaccines, 1976--1977. J Infect Dis. 1978 Nov;138(5):618–624. doi: 10.1093/infdis/138.5.618. [DOI] [PubMed] [Google Scholar]
  10. Stiver H. G., Graves P., Eickhoff T. C., Meiklejohn G. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972. N Engl J Med. 1973 Dec 13;289(24):1267–1271. doi: 10.1056/NEJM197312132892402. [DOI] [PubMed] [Google Scholar]
  11. Wright P. F., Okabe N., McKee K. T., Jr, Maassab H. F., Karzon D. T. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis. 1982 Jul;146(1):71–79. doi: 10.1093/infdis/146.1.71. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES